Latest News- Active Pharmaceutical Ingredients Market: Captive APIs is expected to lead the Manufacturing Type segment during 2025-2029
The Active Pharmaceutical Ingredients Market is being driven by Evolving API manufacturing scenario in developing scenario
The Active Pharmaceutical Ingredients Market is expected to grow at a CAGR of 7.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 97.6 billion. In the pharmaceutical industry, there has been a significant shift from captive Active Pharmaceutical Ingredients (API) manufacturing to outsourcing to Contract Manufacturing Organizations (CMOs) and other drug manufacturing entities. Initially, outsourcing was limited to early-stage API intermediates. However, it has since expanded to encompass advanced intermediates and final dosage forms, particularly in the generic drug sector. Factors influencing this decision include industry trends, the cost of acquiring new in-house technology, and the availability of internal capacity. This outsourcing trend has transformed the global API market landscape.
Get more information on Active Pharmaceutical Ingredients Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Manufacturing Type (Captive APIs, Contract APIs) Type (Innovative APIs, Generic APIs) Geography (Asia, North America, Europe, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Active Pharmaceutical Ingredients Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Active Pharmaceutical Ingredients (API) market encompasses the production and supply of Excipients for Formulation development. Notable players include Chasse-sur-Rhône, Teva Pharmaceutical, and MEDinCell. APIs are integral to treatments for various conditions such as Schizophrenia, chronic diseases, and infectious diseases like HIV/AIDS and Hepatitis C. The market also addresses counterfeit drugs, with research and investment focusing on cancer, oncology drug research, diabetes, and both Small Molecule and Large Molecule therapies. Captive API Manufacturers and Merchant API Manufacturers produce APIs for Biologics, Biosimilars, and key drugs like Acetaminophen and Artemisinin.
The Active Pharmaceutical Ingredients (API) market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or manufacturing of generic and non-generic drugs, as well as veterinary pharmaceuticals. According to Technavio, the healthcare market encompasses the revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the expansion of the pharmaceuticals market include the increasing global population aging, with the number of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe anticipated to reach a similar demographic ratio by 2030. This demographic shift, coupled with the rising prevalence of chronic diseases such as schizophrenia, creates a substantial demand for pharmaceutical solutions. Key industry players include Chasse-sur-Rhône, Teva Pharmaceutical, and MEDinCell, among others.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
